Express News | Phibro Animal Health Corp : BofA Global Research Raises Price Objective to $21 From $15
Phibro Animal Health Corporation's (NASDAQ:PAHC) Prospects Need A Boost To Lift Shares
Rivian Automotive Cuts Production Outlook, Joins EVgo And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Phibro (PAHC) Up 2.9% Since Last Earnings Report: Can It Continue?
Take the Zacks Approach to Beat the Markets: Phibro Animal Health, Travelzoo, Ollie's Bargain Outlet in Focus
Barclays Remains a Sell on Phibro Animal Health (PAHC)
PAHC Stock Gains From Innovation, Market Expansion Goal
JP Morgan Initiates Coverage On Phibro Animal Health With Neutral Rating, Announces Price Target of $22
J.P. Morgan Initiates Phibro Animal Health(PAHC.US) With Hold Rating, Announces Target Price $22
J.P. Morgan analyst Ekaterina Knyazkova initiates coverage on $Phibro Animal Health(PAHC.US)$ with a hold rating, and sets the target price at $22.According to TipRanks data, the analyst has a
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now?
Executives Buying BJ's Restaurants And 2 Other Stocks
Phibro Animal Health Independent Non-Executive Director Acquires 25% More Stock
Director E Corcoran Acquires 5,000 Shares of Phibro Animal Health Corp (PAHC)
Are You Looking for a Top Momentum Pick? Why Phibro Animal Health (PAHC) Is a Great Choice
Implied Volatility Surging for Phibro Animal Health (PAHC) Stock Options
Phibro Animal Health To Go Ex-Dividend On September 4th, 2024 With 0.12 USD Dividend Per Share
September 2nd (Eastern Time) - $Phibro Animal Health(PAHC.US)$ is trading ex-dividend on September 4th, 2024.Shareholders of record on September 4th, 2024 will receive 0.12 USD dividend per share on
Phibro Animal Health Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
B of A Securities Maintains Underperform on Phibro Animal Health, Raises Price Target to $15
Phibro Animal Health Analyst Ratings
BofA Securities Maintains Phibro Animal Health(PAHC.US) With Sell Rating, Raises Target Price to $15
BofA Securities analyst Michael Ryskin maintains $Phibro Animal Health(PAHC.US)$ with a sell rating, and adjusts the target price from $13 to $15.According to TipRanks data, the analyst has a